Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA schedules SARS (severe acute respiratory syndrome) strategy meeting for July:

This article was originally published in Clinica

Executive Summary

The FDA will hold a public workshop on July 14 to discuss methods for evaluating new diagnostic tests for severe acute respiratory syndrome (SARS). The meeting will begin at 8am at the Double Tree, Rockville Hotel, Rockville, Maryland. Pre-registration is required by July 7 and will be accepted on a first-come, first-served basis. Register online at www.fda.gov/cdrh/meetings/071403 or on tel: +1 888 203 6161.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT062681

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel